Management of Viral Meningitis with Cerebral Edema
Introduction to Mannitol Use
- The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) states that osmotic agents such as mannitol have not been studied in randomized controlled trials or comparative studies of meningitis patients, and therefore there is insufficient evidence to guide recommendations for this treatment, applying to both bacterial and viral meningitis contexts 1, 2
- The ESCMID guidelines note that mannitol is not recommended for routine adjuvant therapy in meningitis, based on its primary indication for traumatic brain injury and neurosurgical contexts, not infectious meningitis 1, 2
Recommended Management Approach
- Maintain euvolemia to preserve normal hemodynamic parameters, as fluid restriction to reduce cerebral edema is not recommended, according to the Journal of Infection 4, 5
- Target mean arterial pressure ≥65 mmHg to maintain adequate cerebral perfusion pressure, though this may need adjustment based on age and clinical context, as suggested by the Journal of Infection 4, 5
- Implement basic ICP control measures: head elevation, avoid hyperthermia and hyponatremia, maintain normocarbia and normoglycemia, as recommended by the Praxis Medical Insights 3
- Use crystalloids as initial fluid of choice when intravenous therapy is required, according to the Journal of Infection 4, 5
- Treat seizures early if they occur, as they are associated with worse outcomes and occur in approximately 15% of acute meningitis cases, as noted by the Journal of Infection and Praxis Medical Insights 5, 3
- Consider albumin only for patients with persistent hypotensive shock despite corrective measures, as suggested by the Journal of Infection 4, 5
- Lumbar drainage is the principal intervention for persistently elevated ICP in certain infectious meningitis contexts, not osmotic agents, according to the Praxis Medical Insights 3, 6
Monitoring and Avoiding Pitfalls
- Monitor serum osmolality to ensure it remains below 320 mOsm/L if any osmotic agent is used, as recommended by the Praxis Medical Insights 3, 6
- Routine ICP monitoring is not recommended in meningitis, so clinical assessment and basic measures remain the cornerstone of management, according to the Journal of Infection and Praxis Medical Insights 4, 5, 3
- Do not use osmotic agents routinely, as they lack proven benefit in meningitis and may cause harm, as noted by the Praxis Medical Insights 3, 6
- Do not restrict fluids in an attempt to reduce cerebral edema, as this worsens outcomes, according to the Journal of Infection 4, 5
- Do not delay appropriate antimicrobial therapy while pursuing adjunctive ICP management, as recommended by the Clinical Microbiology and Infection 1
- Do not assume viral meningitis is benign, as patients with altered mental status, seizures, or signs of herniation require critical care monitoring regardless of etiology, according to the Journal of Infection 4